You are here
Search our small molecule opportunities against novel cancer targets and pathways. We have drug discovery, pre-clinical and clinical stage opportunities available for co-development and/or licensing.
CRUK Commercial Partnerships is seeking a partner to progress our lead compounds to clinical investigation for development of Cdc7 inhibition-based cancer therapy.Read more
We are seeking a co-development or licensing partner to drive candidate selection and entry into formal pre-clinical studies.Read more
We are seeking prospective commercial partners with an interest in global therapeutic rights to the FLT3-FAK-VEGFR3 triple kinase inhibitor programme on an exclusive basis.Read more